WASHINGTON — The U.S. Defense Department is weighing a new search for immune-protein “cocktails” it hopes will protect humans against Ebola and other deadly, weapon-usable viruses.
The Pentagon two weeks ago invited scientists to submit research proposals for designing “monoclonal antibodies” that could protect against Ebola and Marburg, as well as “alphaviruses” such as Venezuelan equine encephalitis.
Pentagon planners have been turning to antibodies as a possible tool because “no easy and quick fix” for such agents has emerged from efforts to develop vaccines or traditional antiviral treatments, said Gigi Gronvall, a senior associate with the Center for Health Security at the University of Pittsburgh Medical Center.
The early-stage research now under consideration ideally would lead to single-shot treatments capable of guarding troops for months from multiple virus types, the Defense Threat Reduction Agency said in a Sept. 18 solicitation. DTRA officials welcomed researchers to propose “‘cocktails’ that may enable cross-protection against multiple species of virus.”
The emphasis on “cocktails” makes the latest DTRA proposal particularly notable, because several studies suggest that mixes of several antibodies can be particularly effective in fighting pathogens, Gronvall told Global Security Newswire in a telephone interview. Antibodies hit their targets with such specificity that a treatment with multiple immune proteins can help account for slight variations between invading microbes.
Monoclonal antibodies have been in use since the 1980s to treat cancer and immune-linked ailments such as rheumatoid arthritis, but their use against infectious pathogens has lagged, according to a DTRA-sponsored report co-authored by Gronvall on the technology’s biodefense potential.
The United States last year licensed the first inhalation anthrax treatment to use the technology, which involves creating massive quantities of a single immune “antibody.” The human body naturally generates such proteins, each of which is designed to mark a specific pathogen or toxin for elimination by other immune-system components.
One antibody cocktail grown in modified tobacco plants showed promising potency against Ebola infections specifically, according to a study published in August.
“There have been a lot of changes in the way that monoclonal antibody technologies have evolved over the last several years, and it makes monoclonal antibodies a very nice piece of their approach to medical countermeasures,” Gronvall said.
The latest DTRA Broad Agency Announcement seeks proposals for studies no longer than one year, with a cost no greater than $500 million. The filing deadline is Oct. 16.
What We're Following See More »
Just after President Obama finished his address to the DNC, Hillary Clinton walked out on stage to join him, so the better could share a few embraces, wave to the crowd—and let the cameras capture all the unity for posterity.
In a speech that began a bit like a State of the Union address, President Obama said the "country is stronger and more prosperous than it was" when he took office eight years ago. He then talked of battling Hillary Clinton for the nomination in 2008, and discovering her "unbelievable work ethic," before saying that no one—"not me, not Bill"—has ever been more qualified to be president. When his first mention of Donald Trump drew boos, he quickly admonished the crowd: "Don't boo. Vote." He then added that Trump is "not really a plans guy. Not really a facts guy, either."
Tim Kaine introduced himself to the nation tonight, devoting roughly the first half of his speech to his own story (peppered with a little of his fluent Spanish) before pivoting to Hillary Clinton—and her opponent. "Hillary Clinton has a passion for children and families," he said. "Donald Trump has a passion, too: himself." His most personal line came after noting that his son Nat just deployed with his Marine battalion. "I trust Hillary Clinton with our son's life," he said.
Michael Bloomberg said he wasn't appearing to endorse any party or agenda. He was merely there to support Hillary Clinton. "I don't believe that either party has a monopoly on good ideas or strong leadership," he said, before enumerating how he disagreed with both the GOP and his audience in Philadelphia. "Too many Republicans wrongly blame immigrants for our problems, and they stand in the way of action on climate change and gun violence," he said. "Meanwhile, many Democrats wrongly blame the private sector for our problems, and they stand in the way of action on education reform and deficit reduction." Calling Donald Trump a "dangerous demagogue," he said, "I'm a New Yorker, and a know a con when I see one."
Vice President Biden tonight called President Obama "one of the finest presidents we have ever had" before launching into a passionate defense of Hillary Clinton. "Everybody knows she's smart. Everybody knows she's tough. But I know what she's passionate about," he said. "There's only one person in this race who will help you. ... It's not just who she is; it's her life story." But he paused to train some fire on her opponent "That's not Donald Trump's story," he said. "His cynicism is unbounded. ... No major party nominee in the history of this country has ever known less."